Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 3 |
2015 | 5 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma.
Invest New Drugs. 2015 Feb;33(1):241-6. doi: 10.1007/s10637-014-0169-3. Epub 2014 Oct 16.
Invest New Drugs. 2015.
PMID: 25318437
Clinical Trial.
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma.
Kumar SK, LaPlant B, Chng WJ, Zonder J, Callander N, Fonseca R, Fruth B, Roy V, Erlichman C, Stewart AK; Mayo Phase 2 Consortium.
Kumar SK, et al.
Blood. 2015 Jan 15;125(3):443-8. doi: 10.1182/blood-2014-05-573741. Epub 2014 Nov 13.
Blood. 2015.
PMID: 25395429
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Mattison R, Jumonville A, Flynn PJ, Moreno-Aspitia A, Erlichman C, LaPlant B, Juckett MB.
Mattison R, et al.
Leuk Lymphoma. 2015 Jul;56(7):2061-6. doi: 10.3109/10428194.2014.977886. Epub 2014 Nov 19.
Leuk Lymphoma. 2015.
PMID: 25329007
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study.
Pedersen KS, Kim GP, Foster NR, Wang-Gillam A, Erlichman C, McWilliams RR.
Pedersen KS, et al.
Invest New Drugs. 2015 Aug;33(4):963-8. doi: 10.1007/s10637-015-0246-2. Epub 2015 May 8.
Invest New Drugs. 2015.
PMID: 25952464
Free PMC article.
Clinical Trial.
Item in Clipboard
Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer.
Kummar S, Oza AM, Fleming GF, Sullivan DM, Gandara DR, Naughton MJ, Villalona-Calero MA, Morgan RJ Jr, Szabo PM, Youn A, Chen AP, Ji J, Allen DE, Lih CJ, Mehaffey MG, Walsh WD, McGregor PM 3rd, Steinberg SM, Williams PM, Kinders RJ, Conley BA, Simon RM, Doroshow JH.
Kummar S, et al.
Clin Cancer Res. 2015 Apr 1;21(7):1574-82. doi: 10.1158/1078-0432.CCR-14-2565. Epub 2015 Jan 14.
Clin Cancer Res. 2015.
PMID: 25589624
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite